Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness
Stopped Thirty-five subjects wore the EAS processor for as long as 84 months without significant safety issues. Sufficient data gained to support EAS technology development for safe use in subjects with residual low-frequency acoustic hearing sensitivity.
Conditions
- Hearing Loss
- Partial Deafness
- Hearing Disorders
- Ear Diseases
- Otorhinolaryngologic Diseases
Interventions
- DEVICE: HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode
- DEVICE: EAS sound processor
Sponsor
Advanced Bionics